Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America

This publication has 15 references indexed in Scilit:

• Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer
  Journal of Thoracic Oncology, 2011
• Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation
  Cancer and Metastasis Reviews, 2010
• Genetic Abnormalities of the EGFR Pathway in African American Patients With Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2009
• Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
  New England Journal of Medicine, 2009
• Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
  Clinical Cancer Research, 2008
• Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-treated Non-small Cell Lung Cancer Patients: An Open Label Phase II Study
  Journal of Thoracic Oncology, 2008
• ERBB receptors and cancer: the complexity of targeted inhibitors
  Nature Reviews Cancer, 2005
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
  PLoS Medicine, 2005
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004